Biotechnology - Jensen Beach, Florida, United States
Melanovus Oncology is developing therapeutics for the treatment of metastatic melanoma, which is classified by the FDA as an orphan disease, yet represents a $3B US market and $7.5B WW market. Our approach is novel, and our management team has 120+ years of experience operating under a capital efficient model. We are currently seeking investment to further the development of these target immunotherapies.
Cloudflare DNS
CloudFlare Hosting